Burning Rock focuses on providing comprehensive cancer genomic solutions for pharmaceutical companies from biomarker discovery to commercialization. Powered by our multi-dimensional genomic data from >250,000* cancer patients in China, multimodal central lab testing, integrated companion diagnostic development and commercialization, as well as precision patient recruitment, Burning Rock facillitates the entire process of anti-cancer drug development.
Genomics Data Solutions
Central Lab Testing
CDx Development and Commercialization
Precision Patient Recruitment
Global Support for Drug Clinical Trials
Located in Guangzhou-China, and California-USA, Burning Rock provides global support for drug clinical trials.
US CLIA/CAP Lab:
121 Innovation Drive, Irvine,
CHINA CLIA/CAP Lab:
Room 601, Building 6, Phase 2,
No. 7 LuoXuan 4th Road,
International Biotech Island,
We are committed to providing quality services. Contact us for any questions or concerns:
Email: PBD@brbiotech.com Tel: +8621-6029-3725